Dishman Carbogen Amcis Limited (NSEI: DCAL)
Health Care · Life Sciences Tools & Services · IN
Rs149.68
-0.45% today · -48.8% 1Y
Dishman Carbogen Amcis Limited (NSEI: DCAL) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $242.48M and employs 1,132 people.
Over the last twelve months the share price has lost 48.8%, trading between 128.50 and 303.00.
Tweenvest scores Dishman Carbogen Amcis Limited across four factors: quality 63/100, value 48/100, growth 60/100. Its strongest factor is quality.
DCAL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $242.48M
- Revenue (TTM)
- $306.87M
- P/E
- 145.06
- EPS
- 1.03
- Dividend yield
- —
- Beta (5Y)
- 0.65
- 52-week high
- Rs303.00
- 52-week low
- Rs128.50
- Avg volume (3M)
- —
- Shares outstanding
- 156.78M
- Employees
- 1,132
- Next earnings
- —
About Dishman Carbogen Amcis Limited
Established in 1983 and headquartered in Ahmedabad, India, Dishman Carbogen Amcis Limited provides specialized contract research and manufacturing solutions to the worldwide pharmaceutical sector. The company operates through two main business segments: Contract Research and Manufacturing Services (CR&MS), and Marketable Molecules. Beyond its core services, it manufactures and distributes an extensive portfolio of products, including bulk drugs, chemical intermediates, various phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D derivatives, and fine chemicals. Additionally, its offerings encompass personal care products like hand and body washes, sanitizers, and antiseptics, as well as a range of pharmaceutical and cosmetic formulations, including generic and highly potent active pharmaceutical ingredients. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
- ISIN
- INE385W01011
- Founded
- 1983
- Listed since
- Apr 22, 2004
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Standard BioTools Inc.NasdaqGS: LAB | $270.64M | $0.66 | -4.99% |
| Penetrium Bioscience Inc.KOSDAQ: A187660 | $257.45M | ₩6,320.00 | -9.97% |
| Vimta Labs LimitedBSE: 524394 | $248.09M | Rs537.15 | -7.97% |
| Lifecore Biomedical, Inc.NasdaqGS: LFCR | $244.15M | $6.45 | -0.08% |
| Diaceutics PLCAIM: DXRX | $228.03M | £2.03 | -0.25% |
| Windlas Biotech LimitedNSEI: WINDLAS | $202.39M | Rs949.20 | -12.31% |
| Tarsons Products LimitedNSEI: TARSONS | $176.45M | Rs320.95 | -2.57% |
| Fine Foods & Pharmaceuticals N.T.M. S.p.A.BIT: FF | $168.81M | €6.62 | -1.19% |
Figures last refreshed Oct 11, 2026.